SEARCH

SEARCH BY CITATION

References

  • 1
    Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:130310.
  • 2
    Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:154654.
  • 3
    Silva E, Pedro MA, Sogayar ACB, Mohovic T, Silva CLO, Janiszewski M et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 2004;8:R25660.
  • 4
    Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296327.
  • 5
    Parrillo JE. Mechanisms of disease: pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:14718.
  • 6
    Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004;21:21021.
  • 7
    Van Leeuwen HJ, Van Beek AP, Dallinga-Thie GM, Van Strijp JAG, Verhoef J, Van Kessel KPM. The role of high density lipoprotein in sepsis. Neth J Med 2001;59:10210.
  • 8
    Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic Science. Intensive Care Med 2007;33:1324.
  • 9
    Van Leeuwen HJ, Heezius ECJM, Dallinga GM, Van Strijp JAG, Verhoef J, Van Kessel KPM. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003;31:135966.
  • 10
    Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005;33:168893.
  • 11
    Van Amersfoort ES, Van Berkel TJC, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003;16:379414.
  • 12
    Vincent JL, Abraham E. The last 100 years of sepsis. Am J Respir Crit Care Med 2006;173:25663.
  • 13
    Kitchens RL, Thompson PA, Munford RS, O’Keefe GE. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res 2003;44:2239348.
  • 14
    Gray PW, Flaggs G, Leong SR, Gumina RJ, Weiss J, Ooi CE et al. Cloning of the cDNA of a human neutrophil bactericidal protein: structural and functional correlations. J Biol Chem 1989;264:95059.
  • 15
    Kirschning CJ, Au-Young J, Lamping N, Reuter D, Pfeil D, Seilhamer JJ et al. Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 1997;46:41625.
  • 16
    Connolly DT, Krul ES, Heuvelman D, Glenn KC. Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfate. Biochim Biophys Acta 1996;1304:14560.
  • 17
    Masucci-Magoulas L, Moulis P, Jiang XC, Richardson H, Walsh A, Breslow JL et al. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J Clin Invest 1995;95:158794.
  • 18
    Hardardóttir I, Moser AH, Fuller J, Fielding C, Feingold K, Grünfeld C. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in Syrian hamsters. J Clin Invest 1996;97:258592.
  • 19
    Casita PM, Barbeiro DF, Moretti AI, Quintão EC, Soriano FG. Human cholesteryl ester transfer protein expression enhances the mouse survival rate in an experimental systemic inflammation model: a novel role for CETP. Shock 2008;30:5905.
  • 20
    Levels JHM, Pajkrt D, Schultz M, Hoek FJ, Van Tol A, Meijers JCM et al. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim Biophys Acta 2007;1771:142938.
  • 21
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:12840.
  • 22
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:81829.
  • 23
    Vincent JL, Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998;26:1793800.
  • 24
    Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:86474.
  • 25
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499502.
  • 26
    Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G, Sillero-Arenas M. Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: a prospective study in surgical patients. Infec Control Hosp Epidemiol 1997;18:918.
  • 27
    Gordon BR, Parker TS, Levine DM, Saal SD, Wang JCL, Sloan BJ et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001;29:15638.
  • 28
    Shor R, Wainstein J, Oz D, Boaz M, Matas Z, Fux A et al. Low serum LDL cholesterol levels and risk of fever, sepsis, and malignancy. Ann Clin Lab Sci 2007;37:3438.
  • 29
    Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986;32:1425.
  • 30
    Memis D, Gursoy O, Tasdogan M, Süt N, Kurt I, Türe M et al. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis. J Clin Anesth 2007;19:18691.
  • 31
    Levels JHM, Lemaire LCJM, Van Den Ende AE, Van Deventer SJH, Van Lanschot JB. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. Crit Care Med 2003;31:164753.
  • 32
    Fraunberger P, Pilz G, Cremer P, Werdan K, Walli AK. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 1998;10:35963.
  • 33
    Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988;37:85965.
  • 34
    Gallin JI, Kaye D, O’Leary WM. Serum lipids in infection. N Engl J Med 1969;281:10816.